Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

Rescue Therapy Using a Rifabutin-Based Regimen is Effective for Cure ofHelicobacter pyloriInfection

(2016) Sander Veldhuyzen van Zanten et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

High Helicobacter pylori Resistance to Metronidazole but Zero or Low Resistance to Clarithromycin, Levofloxacin, and Other Antibiotics in Malaysia

(2011) Khean-Lee Goh et al.   HELICOBACTER

Is Culture Necessary before First-line Treatment for Helicobacter pylori Infection?

(2011) Javier P. Gisbert   INTERNAL MEDICINE

One-Week Once-Daily Triple Therapy with Esomeprazole, Moxifloxacin, and Rifabutin for Eradication of Persistent Helicobacter pylori Resistant to Both Metronidazole and Clarithromycin

(2010) Stephan Miehlke et al.   HELICOBACTER

Treatment of Helicobacter pylori Infection 2010

(2010) Anthony O’Connor et al.   HELICOBACTER

Helicobacter pyloriInfection

(2010) Kenneth E.L. McColl   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori

(2010) M. Castro-Fernández et al.   REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis

(2010) Yuqin Li et al.   WIENER KLINISCHE WOCHENSCHRIFT

Past Rifampicin Dosing Determines Rifabutin Resistance of Helicobacter pylori

(2009) Shoji Suzuki et al.   DIGESTION

Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment

(2009) F. Sacco et al.   DIGESTIVE AND LIVER DISEASE

Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK

(2009) S. A. Chisholm et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Cumulative H. pylori Eradication Rates in Clinical Practice by Adopting First and Second-Line Regimens Proposed by the Maastricht III Consensus and a Third-Line Empirical Regimen

(2008) Theodore Rokkas et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Emerging Therapies for the Treatment of Helicobacter pylori Infections

(2008) Tomasz Z Jodlowski et al.   ANNALS OF PHARMACOTHERAPY